Global Digital Pathology Market By Component (Software, Scanner, Services), By Technology (Whole Slide Imaging, Storage, Communication & Integrated Platforms, Others), By Type (Human v/s Veterinary), By Application, By End Users, By Region, Forecast & Opportunities, 2025

The Global Digital Pathology Market is expected to grow at a formidable rate during the forecast period. The Global Digital Pathology Market is driven by the increasing prevalence of diseases especially chronic diseases such as cancer, diabetes, renal diseases, cancer, hepatitis, among others. This has drastically increased the number of patients suffering from these diseases, thereby increasing the need to adopt digital methods of diagnosis which increase the efficiency of diagnosis thereby driving the growth of the market. Furthermore, increasing expenditure by the key vendors operating in the industry on laboratory expansion and enhancement is anticipated to positively impact the growth of the market over the next few years.

The Global Digital Pathology Market is segmented based on component, technology, type, application, end-user, company and region. Based on component, the market can be categorized into software, scanner and services. The software segment is expected to register the highest growth during forecast period owing to the availability of user friendly software with analytical and advanced functions for pathology diagnosis. Based on application, the market can be grouped into drug discovery, disease diagnosis, teleconsultation, training & education and others. The drug discovery segment is expected to dominate the market through 2025. This can be ascribed to the growing R&D expenditure by the major players operating in the market on account of the increasing need for numerous preclinical and clinical studies for drug discovery process. Based on end-user, the market can be fragmented into hospitals & clinics, biotechnology & pharmaceutical companies, research laboratories, contract research organizations and others. The hospitals & clinics segment is expected to dominate the market over the next few years owing to the increase in the number of hospitals & clinics incorporating this technique of diagnostics over the conventional ones.

Regionally, the digital pathology market has been segmented into Asia-Pacific, North America, South America, Europe, and Middle East & Africa. Among these regions, North America is expected to dominate the overall digital pathology market owing to the growing prevalence of chronic diseases in the region. Additionally, favorably reimbursement policies and government support & initiatives are further anticipated to propel the growth of the market in the region.

Major players operating in the Global Digital Pathology Market include Leica Biosystems, Koninklijke Philips N.V., Hamamatsu Photonics, F. Hoffmann-La Roche AG, 3DHISTECH, Apollo Enterprise Imaging, XIFIN, Huron Digital Pathology, Visiopharm A/S, Corista, Indica Labs, Objective Pathology Services, Sectra AB, OptraSCAN, Glencoe Software, KONFOONG BIOTECH INTERNATIONAL CO., LTD, Inspirata, Inc., Mikroscan Technologies, Proscia Inc., Kanteron Systems and others. The companies are developing advanced technologies and launching new services in order to stay competitive in the market. Other competitive strategies include mergers & acquisitions and new service developments.

Years considered for this report:

Historical Years: 2015-2018
Base Year: 2019
Estimated Year: 2020
Forecast Period: 2021–2025

Objective of the Study:

To analyze and estimate the market size of the Global Digital Pathology Market from 2015 to 2018.
To estimate and forecast the market size of the Global Digital Pathology Market from 2019 to 2025 and growth rate until 2025.
To classify and forecast the Global Digital Pathology Market based component, technology, type, application, end-user, company and regional distribution.
To identify dominant region or segment in the Global Digital Pathology Market.
To identify drivers and challenges for the Global Digital Pathology Market.
To examine competitive developments such as expansions, new product launches, mergers & acquisitions, etc., in the Global Digital Pathology Market.
To identify and analyze the profile of leading players operating in the Global Digital Pathology Market.
To identify key sustainable strategies adopted by market players in the Global Digital Pathology Market.

The author performed both primary as well as exhaustive secondary research for this study. Initially, they sourced a list of service providers across the globe. Subsequently, they conducted primary research surveys with the identified companies. While interviewing, the respondents were also enquired about their competitors. Through this technique, they could include the service providers which could not be identified due to the limitations of secondary research. The author analyzed the service providers, distribution channels and presence of all major players across the globe.

The author calculated the market size of the Global Digital Pathology Market by using a bottom-up approach, wherein data for the various end-user segments was recorded and forecast for the future years. They sourced these values from the industry experts and company representatives and externally validated through analyzing historical data of these product types and applications for getting an appropriate, overall market size. Various secondary sources such as company websites, news articles, press releases, company annual reports, investor presentations and financial reports were also studied.

Key Target Audience:

Digital pathology service providers, vendors and other stakeholders
Government bodies such as regulating authorities and policy makers
Organizations, forums and alliances related to digital pathology
Market research and consulting firms

The study is useful in providing answers to several critical questions that are important for the industry stakeholders such as service providers, suppliers, partners, end-users, etc., besides allowing them in strategizing investments and capitalizing on the market opportunities.

Report Scope:
In this report, the Global Digital Pathology Market has been segmented into following categories, in addition to the industry trends which have also been detailed below:

Global Digital Pathology Market, By Component:

Software
Image Analysis Platform
DPIS
Others
Scanner
Brightfield Scanner
Fluorescence Scanner
Services
Installation & Integration
Consulting
Maintenance

Global Digital Pathology Market, By Technology:

Whole Slide Imaging
Storage
Communication & Integrated Platforms
Image Analysis-Informatics
Others

Global Digital Pathology Market, By Type:

Human
Veterinary

Global Digital Pathology Market, By Application:

Drug Discovery
Disease Diagnosis
Teleconsultation
Training & Education
Other

Global Digital Pathology Market, By End-User:

Hospitals & Clinics
Biotechnology & Pharmaceutical Companies
Research Laboratories
Contract Research Organizations
Others

Global Digital Pathology Market, By Region:

North America
United States
Canada
Mexico
Europe
Germany
France
United Kingdom
Italy
Spain
Asia-Pacific
China
Japan
India
South Korea
Australia
Middle East & Africa
South Africa
Saudi Arabia
UAE
Kuwait
South America
Brazil
Argentina
Colombia

Competitive Landscape:

Company Profiles: Detailed analysis of the major companies present in the Global Digital Pathology Market.

Available Customizations:
With the given market data, the author offers customizations according to a client’s specific needs.

1. Product Overview2. Research Methodology3. Executive Summary4. Voice of Customer

5. Global Digital Pathology Market Outlook

5.1. Market Size & Forecast
5.1.1. By Value
5.2. Market Share & Forecast
5.2.1. By Component (Software, Scanner, Services)
5.2.1.1. By Software (Image Analysis Platform, DPIS, Others)
5.2.1.2. By Scanner (Brightfield Scanner v/s Fluorescence Scanner)
5.2.1.3. By Services (Installation & Integration, Consulting, Maintenance)
5.2.2. By Technology (Whole Slide Imaging, Storage, Communication & Integrated Platforms, Image Analysis-Informatics, Others)
5.2.3. By Type (Human v/s Veterinary)
5.2.4. By Application (Drug Discovery, Disease Diagnosis, Teleconsultation, Training & Education, Others)
5.2.5. By End Users (Hospitals & Clinics, Biotechnology & Pharmaceutical Companies, Research Laboratories, Contract Research Organizations, Others)
5.2.6. By Company (2019)
5.2.7. By Region
5.3. Product Market Map

6. Asia-Pacific Digital Pathology Market Outlook

6.1. Market Size & Forecast
6.1.1. By Value
6.2. Market Share & Forecast
6.2.1. By Component
6.2.2. By Technology
6.2.3. By Type
6.2.4. By Application
6.2.5. By End User
6.2.6. By Country
6.3. Asia-Pacific: Country Analysis
6.3.1. China Digital Pathology Market Outlook
6.3.1.1. Market Size & Forecast
6.3.1.1.1. By Value
6.3.1.2. Market Share & Forecast
6.3.1.2.1. By Technology
6.3.1.2.2. By Type
6.3.1.2.3. By Application
6.3.1.2.4. By End User
6.3.2. India Digital Pathology Market Outlook
6.3.2.1. Market Size & Forecast
6.3.2.1.1. By Value
6.3.2.2. Market Share & Forecast
6.3.2.2.1. By Technology
6.3.2.2.2. By Type
6.3.2.2.3. By Application
6.3.2.2.4. By End User
6.3.3. Australia Digital Pathology Market Outlook
6.3.3.1. Market Size & Forecast
6.3.3.1.1. By Value
6.3.3.2. Market Share & Forecast
6.3.3.2.1. By Technology
6.3.3.2.2. By Type
6.3.3.2.3. By Application
6.3.3.2.4. By End User
6.3.4. Japan Digital Pathology Market Outlook
6.3.4.1. Market Size & Forecast
6.3.4.1.1. By Value
6.3.4.2. Market Share & Forecast
6.3.4.2.1. By Technology
6.3.4.2.2. By Type
6.3.4.2.3. By Application
6.3.4.2.4. By End User
6.3.5. South Korea Digital Pathology Market Outlook
6.3.5.1. Market Size & Forecast
6.3.5.1.1. By Value
6.3.5.2. Market Share & Forecast
6.3.5.2.1. By Technology
6.3.5.2.2. By Type
6.3.5.2.3. By Application
6.3.5.2.4. By End User

7. Europe Digital Pathology Market Outlook

7.1. Market Size & Forecast
7.1.1. By Value
7.2. Market Share & Forecast
7.2.1. By Component
7.2.2. By Technology
7.2.3. By Type
7.2.4. By Application
7.2.5. By End User
7.2.6. By Country
7.3. Europe: Country Analysis
7.3.1. France Digital Pathology Market Outlook
7.3.1.1. Market Size & Forecast
7.3.1.1.1. By Value
7.3.1.2. Market Share & Forecast
7.3.1.2.1. By Technology
7.3.1.2.2. By Type
7.3.1.2.3. By Application
7.3.1.2.4. By End User
7.3.2. Germany Digital Pathology Market Outlook
7.3.2.1. Market Size & Forecast
7.3.2.1.1. By Value
7.3.2.2. Market Share & Forecast
7.3.2.2.1. By Technology
7.3.2.2.2. By Type
7.3.2.2.3. By Application
7.3.2.2.4. By End User
7.3.3. United Kingdom Digital Pathology Market Outlook
7.3.3.1. Market Size & Forecast
7.3.3.1.1. By Value
7.3.3.2. Market Share & Forecast
7.3.3.2.1. By Technology
7.3.3.2.2. By Type
7.3.3.2.3. By Application
7.3.3.2.4. By End User
7.3.4. Italy Digital Pathology Market Outlook
7.3.4.1. Market Size & Forecast
7.3.4.1.1. By Value
7.3.4.2. Market Share & Forecast
7.3.4.2.1. By Technology
7.3.4.2.2. By Type
7.3.4.2.3. By Application
7.3.4.2.4. By End User
7.3.5. Spain Digital Pathology Market Outlook
7.3.5.1. Market Size & Forecast
7.3.5.1.1. By Value
7.3.5.2. Market Share & Forecast
7.3.5.2.1. By Technology
7.3.5.2.2. By Type
7.3.5.2.3. By Application
7.3.5.2.4. By End User

8. North America Digital Pathology Market Outlook

8.1. Market Size & Forecast
8.1.1. By Value
8.2. Market Share & Forecast
8.2.1. By Component
8.2.2. By Technology
8.2.3. By Type
8.2.4. By Application
8.2.5. By End User
8.2.6. By Country
8.3. North America: Country Analysis
8.3.1. United States Digital Pathology Market Outlook
8.3.1.1. Market Size & Forecast
8.3.1.1.1. By Value
8.3.1.2. Market Share & Forecast
8.3.1.2.1. By Technology
8.3.1.2.2. By Type
8.3.1.2.3. By Application
8.3.1.2.4. By End User
8.3.2. Mexico Digital Pathology Market Outlook
8.3.2.1. Market Size & Forecast
8.3.2.1.1. By Value
8.3.2.2. Market Share & Forecast
8.3.2.2.1. By Technology
8.3.2.2.2. By Type
8.3.2.2.3. By Application
8.3.2.2.4. By End User
8.3.3. Canada Digital Pathology Market Outlook
8.3.3.1. Market Size & Forecast
8.3.3.1.1. By Value
8.3.3.2. Market Share & Forecast
8.3.3.2.1. By Technology
8.3.3.2.2. By Type
8.3.3.2.3. By Application
8.3.3.2.4. By End User

9. South America Digital Pathology Market Outlook

9.1. Market Size & Forecast
9.1.1. By Value
9.2. Market Share & Forecast
9.2.1. By Component
9.2.2. By Technology
9.2.3. By Type
9.2.4. By Application
9.2.5. By End User
9.2.6. By Country
9.3. South America: Country Analysis
9.3.1. Brazil Digital Pathology Market Outlook
9.3.1.1. Market Size & Forecast
9.3.1.1.1. By Value
9.3.1.2. Market Share & Forecast
9.3.1.2.1. By Technology
9.3.1.2.2. By Type
9.3.1.2.3. By Application
9.3.1.2.4. By End User
9.3.2. Argentina Digital Pathology Market Outlook
9.3.2.1. Market Size & Forecast
9.3.2.1.1. By Value
9.3.2.2. Market Share & Forecast
9.3.2.2.1. By Technology
9.3.2.2.2. By Type
9.3.2.2.3. By Application
9.3.2.2.4. By End User
9.3.3. Colombia Digital Pathology Market Outlook
9.3.3.1. Market Size & Forecast
9.3.3.1.1. By Value
9.3.3.2. Market Share & Forecast
9.3.3.2.1. By Technology
9.3.3.2.2. By Type
9.3.3.2.3. By Application
9.3.3.2.4. By End User

10. Middle East and Africa Digital Pathology Market Outlook

10.1. Market Size & Forecast
10.1.1. By Value
10.2. Market Share & Forecast
10.2.1. By Component
10.2.2. By Technology
10.2.3. By Type
10.2.4. By Application
10.2.5. By End User
10.2.6. By Country
10.3. MEA: Country Analysis
10.3.1. South Africa Digital Pathology Market Outlook
10.3.1.1. Market Size & Forecast
10.3.1.1.1. By Value
10.3.1.2. Market Share & Forecast
10.3.1.2.1. By Technology
10.3.1.2.2. By Type
10.3.1.2.3. By Application
10.3.1.2.4. By End User
10.3.2. Saudi Arabia Digital Pathology Market Outlook
10.3.2.1. Market Size & Forecast
10.3.2.1.1. By Value
10.3.2.2. Market Share & Forecast
10.3.2.2.1. By Technology
10.3.2.2.2. By Type
10.3.2.2.3. By Application
10.3.2.2.4. By End User
10.3.3. UAE Digital Pathology Market Outlook
10.3.3.1. Market Size & Forecast
10.3.3.1.1. By Value
10.3.3.2. Market Share & Forecast
10.3.3.2.1. By Technology
10.3.3.2.2. By Type
10.3.3.2.3. By Application
10.3.3.2.4. By End User
10.3.4. Kuwait Digital Pathology Market Outlook
10.3.4.1. Market Size & Forecast
10.3.4.1.1. By Value
10.3.4.2. Market Share & Forecast
10.3.4.2.1. By Technology
10.3.4.2.2. By Type
10.3.4.2.3. By Application
10.3.4.2.4. By End User

11. Market Dynamics

11.1. Drivers
11.2. Challenges

12. Market Trends & Developments

13. Competitive Landscape

13.1. Leica Biosystems
13.2. Koninklijke Philips N.V.
13.3. Hamamatsu Photonics
13.4. F. Hoffmann-La Roche AG
13.5. 3DHISTECH
13.6. Apollo Enterprise Imaging
13.7. XIFIN
13.8. Huron Digital Pathology
13.9. Visiopharm A/S
13.10. Corista
13.11. Indica Labs
13.12. Objective Pathology Services
13.13. Sectra AB
13.14. OptraSCAN
13.15. Glencoe Software
13.16. KONFOONG BIOTECH INTERNATIONAL CO., LTD
13.17. Inspirata, Inc.
13.18. Mikroscan Technologies
13.19. Proscia Inc.
13.20. Kanteron Systems

14. Strategic Recommendations15. About Us & Disclaimer